Table 1.
Control group (n = 21) | Dexmedetomidine group (n = 21) | P value | |
---|---|---|---|
Age (years) | 32 (5)a | 29 (4) | 0.05 |
BMI (kg/m2) | 45 (3)a | 48 (4) | 0.03 |
Smoking | 5 (25%) | 6 (29%) | 0.95 |
COPD, emphysema | 0(%) | 0 (0%) | 1 |
FVC (% predicted) | 65 (61,67) | 62 (60,66) | 0.28 |
FEV1/FVC (%) | 81 (78,84) | 80 (77,83) | 0.33 |
Baseline PaCO2 (mmHg) | 42 (7) | 39 (5) | 0.1 |
Surgical duration | 113 (19) | 109 (18) | 0.5 |
Intraoperative fluids | 844 (101) | 831 (103) | 0.7 |
Blood loss | 238 (76) | 258 (78) | 0.4 |
Postoperative complications | |||
- ICU admission | 3 (14%) | 2 (10%) | 0.9 |
- Invasive ventilation | 2 (10%) | 1 (5%) | 1 |
- Anastomotic leakage | 0 (0%) | 0 (0%) | 1 |
- Bleeding | 0 (0%) | 0 (0%) | 1 |
- Pneumonia | 0 (0%) | 0 (0%) | 1 |
- 28-day death | 0 (0%) | 0 (0%) | 1 |
POSS | 2 (1,2) | 2 (1,2) | 1 |
BMI Body mass index, COPD Chronic obstructive pulmonary disease, FEV1 Forced expiratory volume in the first second, FVC Forced vital capacity, ICU intensive care unit, POSS Pasero opioid-induced sedation scale, P/F ratio PaO2/fraction of inspired oxygen
adenotes statistical significance between both groups